ArticleJournal of hematology & oncology2021

Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy.

Hye-Ran Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.